l‐Carnitine and heart disease

  title={l‐Carnitine and heart disease},
  author={Zhongyao Wang and Ying-Yi Liu and Guo-hui Liu and Hai‐Bin Lu and Cuiying Mao},
  journal={Life Sciences},

Figures from this paper

Role of carnitine in regulation of blood pressure (MAP/SBP) and gene expression of cardiac hypertrophy markers (α/β‐MHC) during insulin‐induced hypoglycaemia: Role of oxidative stress

It is demonstrated that carnitine might play an essential role in prevention of hypoglycaemia‐induced hypertension and cardiac hypertrophy through providing energy and antioxidants to the cardiovascular system.

Role of carnitine in regulation of hypoglycemia-induced hypertension and cardiac hypertrophy

It is demonstrated that carnitine plays an essential role in providing energy and antioxidants to the cardiovascular system leading to the prevention of hypoglycemia-induced hypertension and cardiac hypertrophy.

l-carnitine, a friend or foe for cardiovascular disease? A Mendelian randomization study

The findings do not support a beneficial association of l-carnitine with CVD and its risk factors but suggest potential harm.

L-Carnitine: An Antioxidant Remedy for the Survival of Cardiomyocytes under Hyperglycemic Condition

This novel study demonstrates that LC improves the microenvironment damaged by oxidative stress (induced by hyperglycemia), thus proposing this nutraceutical compound as an adjuvant in diabetic cardiac regenerative medicine.

The protective effects of L‐carnitine on myocardial ischaemia–reperfusion injury in patients with rheumatic valvular heart disease undergoing CPB surgery are associated with the suppression of NF‐κB pathway and the activation of Nrf2 pathway

L‐carnitine had a protective effect against CPB‐induced MIRI in patients with RVHD, which might be related to its modulation of NF‐κB and Nrf2 activities.

Carnitine and its Derivatives as a Potential Option for Cardiovascular, Neurologic and Metabolic Complications of COVID-19

Considering the safety profile of carnitine, it may have promising clinical results in alleviating COVID-19 severity and its complications, and may act as a protective antioxidant against SARS-Cov-2 infection by modulating proinflammatory cytokines.

L-Carnitine Alleviates the Myocardial Infarction and Left Ventricular Remodeling through Bax/Bcl-2 Signal Pathway

The data suggest that LC can effectively ameliorate left ventricular (LV) remodeling after MI, and its beneficial effects on myocardial function and remodeling may be attributable at least in part to anti-inflammatory and inhibition of the Bax/Bcl-2 apoptotic signaling pathway.

L-Carnitine supplementation reduces biomarkers of inflammatory and oxidative stress in patients with coronary artery disease: a randomised controlled trial.

It is suggested that LC supplementation may exert beneficial effect on cardiovascular health through attenuate oxidative and inflammatory markers in CAD patients.

Gut microbiota production of trimethyl-5-aminovaleric acid reduces fatty acid oxidation and accelerates cardiac hypertrophy

Data suggest that the gut microbiota-derived TMAVA is a key determinant for the development of cardiac hypertrophy through inhibition of carnitine synthesis and subsequent FAO.

Metabolomics Analysis Reveals Deranged Energy Metabolism and Amino Acid Metabolic Reprogramming in Dogs With Myxomatous Mitral Valve Disease

Altered energy metabolism, amino acid metabolic programming, and reduced renal function in the development of MMVD and CHF is revealed, including complex interplays along the heart‐kidney‐gut axis.



L-Carnitine prevents the development of ventricular fibrosis and heart failure with preserved ejection fraction in hypertensive heart disease

L-carnitine supplementation attenuates cardiac fibrosis by increasing prostacyclin production through arachidonic acid pathway, and may be a promising therapeutic option for HFpEF.

Translating the basic knowledge of mitochondrial functions to metabolic therapy: role of L-carnitine.

L-carnitine attenuates cardiac remodelling rather than vascular remodelling in deoxycorticosterone acetate-salt hypertensive rats.

It is suggested that the mitochondrial respiratory chain is a significant source of reactive oxygen species in the heart but less so in the vasculature in DOCA-salt rats, underlying the relatively selective cardiac responses to L-carnitine treatment.

The role of carnitine in myocardial dysfunction.

  • D. PaulyC. Pepine
  • Medicine, Biology
    American journal of kidney diseases : the official journal of the National Kidney Foundation
  • 2003

Combined metabolomic and proteomic analysis of human atrial fibrillation.

Metabolic mechanisms in heart failure.

The cellular mechanisms and pathophysiology of altered metabolism and insulin resistance in heart failure, and appropriate therapies to mitigate aberrant metabolism include intense neurohumoral antagonism, limitation of diuretics, correction of hypokalemia, exercise, and diet are reviewed.

Myocardial energetics and the role of micronutrients in heart failure: a critical review.

Evidence from the studies show that using high doses of multiple micronutrients may have positive effects on heart failure and simultaneously support the myocardial energy depletion hypothesis.

A Moderate Carnitine Deficiency Exacerbates Isoproterenol-Induced Myocardial Injury in Rats

This study suggests that carnitine deficiency exposes the heart to a greater risk of injury when sympathetic nerve activity is greatly stimulated, for example during emotional, mental or physical stress.